NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $1.5B
- YoY, 2025
- +37.6%
- 5-year CAGR
- +13.1%
- 10-year CAGR
- +14.6%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $1.5B | +37.6% |
| 2024 | $1.1B | +4.3% |
| 2023 | $1.0B | +4.3% |
| 2022 | $989M | +39.1% |
| 2021 | $711M | −11.2% |
| 2020 | $801M | +19.5% |
| 2019 | $671M | +3.0% |
| 2018 | $651M | +26.2% |
| 2017 | $516M | +67.9% |
| 2016 | $307M | −18.9% |
| 2015 | $379M | +95.7% |
| 2014 | $194M | +33.0% |
| 2013 | $146M | −15.8% |
| 2012 | $173M | +34.0% |
| 2011 | $129M | +1.8% |
| 2010 | $127M | +239.9% |
| 2009 | $37M | — |